Statin therapy for hypertrophic cardiomyopathy: too good to be true?

Karam M. Kostner,

Karam M. Kostner

University of Queensland, Brisbane, Qld, Australia

Search for more papers by this author

Karam M. Kostner,

Karam M. Kostner

University of Queensland, Brisbane, Qld, Australia

Search for more papers by this author

First published: 16 September 2010

https://doi.org/10.1111/j.1365-2362.2010.02377.x

Citations: 5

Address
University of Queensland, Mater Adult Hospital, Brisbane, Qld, Australia (K. M. Kostner).
Correspondence to: Karam M. Kostner, University of Queensland, Mater Adult Hospital, Brisbane, Qld 4101, Australia. Tel.: +61 7 3163 6793; fax: +61 7 3010 5781; e-mail: [email protected]

See paper on page 976.

Share a link

Email
Wechat
Bluesky

References

1 Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005; 366: 1267–78.
10.1016/S0140-6736(05)67394-1
CAS PubMed Web of Science® Google Scholar
2 Kruger PS. Statins: the next anti-endotoxin. Crit Care Resusc 2006; 8: 223–6.
PubMed Google Scholar
3 Maron BJ, Doerer JJ, Haas TS, Tierney DM, Mueller FO. Sudden deaths in young competitive athletes. Clinical, demographic and pathological profiles. JAMA 1996; 276: 199–204.
CAS PubMed Web of Science® Google Scholar
4 Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic Implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322: 1561–6.
10.1056/NEJM199005313222203
CAS PubMed Web of Science® Google Scholar
5 Marian AJ. Experimental therapies in hypertrophic cardiomyopathy. J Cardiovasc Transl Res 2009; 2: 483–92.
10.1007/s12265-009-9132-7
PubMed Web of Science® Google Scholar
6 Takemoto M, Node K, Nakagami H, Liao Y, Grimm M, Takemoto Y et al. Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy. J Clin Invest 2001; 108: 1429–37.
10.1172/JCI13350
CAS PubMed Web of Science® Google Scholar
7 Patel R, Nagueh SF, Tsybouleva N, Abdellatif M, Lutucuta S, Kopelen HA et al. Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy. Circulation 2001; 104: 317–24.
10.1161/hc2801.094031
CAS PubMed Web of Science® Google Scholar
8 Senthil V, Chen SN, Tsybouleva N, Halder T, Nagueh SF, Willerson JT et al. Prevention of cardiac hypertrophy by atorvastatin in a transgenic rabbit model of human hypertrophic cardiomyopathy. Circ Res 2005; 97: 285–92.
10.1161/01.RES.0000177090.07296.ac
CAS PubMed Web of Science® Google Scholar
9 Chen MS, Xu FP, Wang YZ, Zhang GP, Yi Q, Zhang HQ et al. Statins initiated after hypertrophy inhibit oxidative stress and prevent heart failure in rats with aortic stenosis. J Mol Cell Cardiol 2004; 37: 889–96.
10.1016/j.yjmcc.2004.06.019
CAS PubMed Web of Science® Google Scholar
10 Luo JD, Zhang WW, Zhang GP, Guan JX, Chen X. Simvastatin inhibits cardiac hypertrophy and angiotensin-converting enzyme activity in rats with aortic stenosis. Clin Exp Pharmacol Physiol 1999; 26: 903–8.
10.1046/j.1440-1681.1999.03165.x
CAS PubMed Web of Science® Google Scholar
11 Indolfi C, Di Lorenzo E, Perrino C, Stingone AM, Curcio A, Torella D et al. Hydroxymethylglutaryl coenzyme A reductase inhibitor simvastatin prevents cardiac hypertrophy induced by pressure overload and inhibits p21ras activation. Circulation 2002; 106: 2118–24.
10.1161/01.CIR.0000034047.70205.97
CAS PubMed Web of Science® Google Scholar
12 Nishikawa L, Miura S, Zhang B, Shimomura H, Arai H. Statins induce the regression of left ventricular mass in patients with angina. Circ J 2004; 68: 121–5.
10.1253/circj.68.121
CAS PubMed Web of Science® Google Scholar
13 Bauersachs J, Stork S, Kung M, Waller C, Fidler F, Hoyer C et al. HMG CoA reductase inhibition and left ventricular mass in hypertrophic cardiomyopathy: a randomized placebo-controlled pilot study. Eur J Clin Invest 2007; 37: 852–9.
10.1111/j.1365-2362.2007.01877.x
CAS PubMed Web of Science® Google Scholar
14 Nagueh SF, Lombardi R, Tan Y, Wang J, Willerson JT, Marian AJ. Atorvastatin and cardiac hypertrophy and function in hypertrophic cardiomyopathy: a pilot study. Eur J Clin Invest 2010; 40: 976–83.
10.1111/j.1365-2362.2010.02349.x
CAS PubMed Web of Science® Google Scholar

Citing Literature

Volume40, Issue11

November 2010

Pages 965-967

Statin therapy for hypertrophic cardiomyopathy: too good to be true?

References

Citing Literature

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

Statin therapy for hypertrophic cardiomyopathy: too good to be true?

References

Citing Literature

References

Related

Information